Effects of Valsartan Therapy on QT Interval Dispersion in Congestive Heart Failure
作者： Sorana D. Bolboacă , Ştefania Luminiţa Suta Negrea
DOI:
关键词:
摘要: Aim: The aim of the research was to investigate effects Valsartan therapy on QT interval dispersion (QTd) in patients with Chronic Heart Failure (CHF). Material and Method: A sample ambulatory patients, aged 22-79 years NYHA class II IV, ventricular ejection fraction 65 (n = 36). At 6 months, there were identified both groups that QTd significantly decreased comparing baseline values (85 ms vs 112 ms; Wilcoxon Z 7.77, n 80, p years. reduction CHF using could be responsible by risk sudden cardiac death investigated group.
cabdirect.org
umfcluj.ro参考文章(15)
John G.F. Cleland, Sudipta Chattopadhyay, Aleem Khand, Timothy Houghton, Gerald C. Kaye, Prevalence and Incidence of Arrhythmias and Sudden Death in Heart Failure Heart Failure Reviews. ,vol. 7, pp. 229- 242 ,(2002) , 10.1023/A:1020024122726
Jay N. Cohn, Gianni Tognoni, Robert D. Glazer, Dirk Spormann, Allen Hester, Rationale and design of the valsartan heart failure trial: A large multinational trial to assess the effects of valsartan, an angiotensin-receptor blocker, on morbidity and mortality in chronic congestive heart failure Journal of Cardiac Failure. ,vol. 5, pp. 155- 160 ,(1999) , 10.1016/S1071-9164(99)90038-6
J.M. Glancy, C.J. Garratt, D.P. de Bono, K.L. Woods, QT dispersion and mortality after myocardial infarction The Lancet. ,vol. 345, pp. 945- 948 ,(1995) , 10.1016/S0140-6736(95)90697-5
Anne M Gillis, Mouhieddin Traboulsi, John T.Y Hii, D.George Wyse, Henry J Duff, Margot McDonald, L.Brent Mitchell, Antiarrhythmic Drug Effects on QT Interval Dispersion in Patients Undergoing Electropharmacologic Testing for Ventricular Tachycardia and Fibrillation American Journal of Cardiology. ,vol. 81, pp. 588- 593 ,(1998) , 10.1016/S0002-9149(97)00967-3
Juha S. Perkiömaki, M. Juhani Koistinen, Sinikka Yli-mayry, Heikki V. Huikuri, Dispersion of QT interval in patients with and without susceptibility to ventricular tachyarrhythmias after previous myocardial infarction Journal of the American College of Cardiology. ,vol. 26, pp. 174- 179 ,(1995) , 10.1016/0735-1097(95)00122-G
for the captopril-digoxin study group. Gradman A, Deedwania P, Cody R, Massie B, Packer M, None, Predictors of total mortality and sudden death in mild to moderate heart failure Journal of the American College of Cardiology. ,vol. 14, pp. 564- 570 ,(1989) , 10.1016/0735-1097(89)90093-4
DEBORAH J. STATTERS, MAREK MALIK, DAVID E. WARD, A. JOHN CAMM, QT dispersion: problems of methodology and clinical significance. Journal of Cardiovascular Electrophysiology. ,vol. 5, pp. 672- 685 ,(1994) , 10.1111/J.1540-8167.1994.TB01190.X
Piet Finckenberg, Saara Merasto, Marjut Louhelainen, Leena Lindgren, Heikki Vapaatalo, Dominik N M??ller, Friedrich C Luft, Eero MA Mervaala, Magnesium supplementation prevents angiotensin II-induced myocardial damage and CTGF overexpression Journal of Hypertension. ,vol. 23, pp. 375- 380 ,(2005) , 10.1097/00004872-200502000-00020
Jay N. Cohn, Gianni Tognoni, A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. The New England Journal of Medicine. ,vol. 345, pp. 1667- 1675 ,(2001) , 10.1056/NEJMOA010713
T. Kahan, Left ventricular hypertrophy in hypertension: its arrhythmogenic potential Heart. ,vol. 91, pp. 250- 256 ,(2005) , 10.1136/HRT.2004.042473